Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Robust response to pembrolizumab in temozolomide-associated hypermutated and microsatellite instability-high functional pancreatic neuroendocrine tumor
Saved in:
| Published in: | The Oncologist |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Robust response to pembrolizumab in temozolomide-associated hypermutated and microsatellite instability-high functional pancreatic neuroendocrine tumor
- Patient-reported symptom and urgent healthcare use in neuroendocrine tumors
- Multimodal management of hormonal and oncological progression in PTHrP-secreting pancreatic neuroendocrine tumours
- Mesenteric paraganglioma mimicking nodal metastasis of an occult small intestinal neuroendocrine tumor
- Temozolomide reconsidered: Real-World evidence in resistant melanoma cases
- Can clinicians predict individual patient outcomes in neuroendocrine tumors treated with [177Lu]Lu-DOTATATE?
- Targeting Temozolomide‐Resistant Glioblastoma: Therapeutic Potential of Neuronal Nitric Oxide Synthase Inhibitor